• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对患者来源的恶性胸腔和腹腔积液进行体外细胞培养以进行个性化药物筛选。

In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening.

作者信息

Wu Cheng-Guang, Chiovaro Francesca, Curioni-Fontecedro Alessandra, Casanova Ruben, Soltermann Alex

机构信息

Institute of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland.

University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland.

出版信息

J Transl Med. 2020 Apr 10;18(1):163. doi: 10.1186/s12967-020-02331-x.

DOI:10.1186/s12967-020-02331-x
PMID:32276643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7149866/
Abstract

BACKGROUND

Malignant serous effusion (MSE) denotes a manifestation of metastatic disease with typical high concentrations of both cancer and immune cells, making them an ideal resource for in vitro cytologic studies. Hence, the aim of the study was to investigate the features of 2D and 3D MSE culture systems as well as their feasibilities for in vitro drug screening.

METHODS

Pleural and peritoneal effusions from 8 patients were collected and processed for 2D monolayer and 3D hanging drop cell culture into GravityPLUS™ plates. Representative markers for cell components, proliferation rate and tumour classification were investigated by immunohistochemistry, followed by absolute quantification using a digitalised image analysis approach. Further, we implemented another 3D cell culture model based on a low attachment method for in vitro drug sensitivity testing of carboplatin, pemetrexed and pembrolizumab for 5 patients.

RESULTS

Monolayer cell culture was favourable for the growth of mesothelial cells, while hanging drop culture in GravityPLUS™ plates showed better ability for preserving cancer cells, inducing positive diagnostic markers expression and restraining the growth of mesothelial cells. For in vitro drug testing, MSE from five patients presented various drug sensitivities, and one case showed strong response to PD-1 checkpoint inhibition (pembrolizumab). For some patients, the application of combinatorial drugs had better therapeutic responses compared to monotherapy.

CONCLUSIONS

Digitalised quantification of data offers a better understanding of different MSE culture models. More importantly, the proposed platforms are practical and amenable for performing in vitro chemo-/immunotherapeutic drug testing by using routine cytologic MSE in a personalised manner. Next to cell blocks, our work demonstrates the prognostic and predictive value of cytologic effusion samples.

摘要

背景

恶性浆液性积液(MSE)是转移性疾病的一种表现,其中癌细胞和免疫细胞浓度通常较高,使其成为体外细胞学研究的理想资源。因此,本研究的目的是探讨二维和三维MSE培养系统的特征及其在体外药物筛选中的可行性。

方法

收集8例患者的胸腔和腹腔积液,处理后用于二维单层和三维悬滴细胞培养,接种到GravityPLUS™平板中。通过免疫组织化学研究细胞成分、增殖率和肿瘤分类的代表性标志物,随后使用数字化图像分析方法进行绝对定量。此外,我们基于低附着方法实施了另一种三维细胞培养模型,用于对5例患者的卡铂、培美曲塞和帕博利珠单抗进行体外药敏试验。

结果

单层细胞培养有利于间皮细胞生长,而在GravityPLUS™平板中进行悬滴培养在保存癌细胞、诱导阳性诊断标志物表达和抑制间皮细胞生长方面表现出更好的能力。对于体外药物测试,5例患者的MSE呈现出不同的药物敏感性,1例对PD-1检查点抑制(帕博利珠单抗)表现出强烈反应。对于一些患者,联合用药比单一疗法具有更好的治疗反应。

结论

数据的数字化定量有助于更好地理解不同的MSE培养模型。更重要的是,所提出的平台实用且适合以个性化方式使用常规细胞学MSE进行体外化学/免疫治疗药物测试。除了细胞块,我们的工作证明了细胞学积液样本的预后和预测价值。

相似文献

1
In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening.对患者来源的恶性胸腔和腹腔积液进行体外细胞培养以进行个性化药物筛选。
J Transl Med. 2020 Apr 10;18(1):163. doi: 10.1186/s12967-020-02331-x.
2
Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.抗L523S抗体在良恶性浆液性积液诊断中的应用
Cancer. 2008 Feb 25;114(1):49-56. doi: 10.1002/cncr.23254.
3
Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.小型嗜橘红色类鳞状细胞:胸腔积液细胞学中诊断恶性间皮瘤的一种被低估但有用的形态学特征。
Cancer Cytopathol. 2014 Jan;122(1):70-5. doi: 10.1002/cncy.21345. Epub 2013 Aug 26.
4
Serous effusions in malignant lymphomas: a review.恶性淋巴瘤中的浆液性积液:综述
Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432.
5
A panel of markers for identification of malignant and non-malignant cells in culture from effusions.一组用于鉴定培养液渗出液中恶性和非恶性细胞的标志物。
Oncol Rep. 2017 Dec;38(6):3538-3544. doi: 10.3892/or.2017.6022. Epub 2017 Oct 11.
6
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.用于个性化癌症医学的患者来源恶性胸腔积液的培养与药物分析
PLoS One. 2016 Aug 22;11(8):e0160807. doi: 10.1371/journal.pone.0160807. eCollection 2016.
7
IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.IMP3/L523S,一种新型免疫细胞化学标志物,可区分良恶性细胞:IMP3/L523S 在积液细胞学中的表达谱。
Hum Pathol. 2010 May;41(5):745-50. doi: 10.1016/j.humpath.2009.04.030. Epub 2010 Jan 13.
8
Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.转移性积液间皮细胞的增殖率低于良性积液。
Anal Quant Cytol Histol. 2007 Aug;29(4):217-20.
9
Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology.浆液性积液中细胞的组织培养。作为细胞学辅助手段的评估。
Acta Cytol. 1978 Nov-Dec;22(6):487-9.
10
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.恶性胸腔积液中胸腔积液细胞学检查的诊断阳性率。
Singapore Med J. 2000 Jan;41(1):19-23.

引用本文的文献

1
A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion.一种反映恶性胸腔积液非小细胞肺癌对免疫检查点抑制剂治疗反应的新型生物测定法。
Transl Lung Cancer Res. 2024 Dec 31;13(12):3267-3277. doi: 10.21037/tlcr-24-559. Epub 2024 Dec 19.
2
High-Throughput Separation and Enrichment of Rare Malignant Tumor Cells from Large-Volume Effusions by Inertial Microfluidics.基于惯性微流控的大容量浆膜腔积液中稀有恶性肿瘤细胞的高通量分离富集。
Methods Mol Biol. 2023;2679:193-206. doi: 10.1007/978-1-0716-3271-0_13.
3
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.

本文引用的文献

1
Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis.通过计算机化免疫组织化学和转录分析对恶性胸腔积液患者进行预后免疫细胞分析
Cancers (Basel). 2019 Dec 5;11(12):1953. doi: 10.3390/cancers11121953.
2
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.帕博利珠单抗联合化疗治疗转移性非小细胞肺癌。
N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.
3
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.
利用患者来源的类器官预测局部晚期或转移性肺癌肿瘤的反应:一项真实世界的研究。
Cell Rep Med. 2023 Feb 21;4(2):100911. doi: 10.1016/j.xcrm.2022.100911. Epub 2023 Jan 18.
4
Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival.处于热适应性免疫状态的肺腺癌伴恶性胸腔积液患者总生存期更长。
Front Oncol. 2022 Oct 4;12:1031094. doi: 10.3389/fonc.2022.1031094. eCollection 2022.
晚期鳞状非小细胞肺癌中伊匹单抗联合紫杉醇和卡铂的 III 期试验。
J Clin Oncol. 2017 Oct 20;35(30):3449-3457. doi: 10.1200/JCO.2016.71.7629. Epub 2017 Aug 30.
4
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.贝伐珠单抗联合紫杉醇-卡铂化疗和二次细胞减灭术治疗复发性铂敏感型卵巢癌(NRG 肿瘤学/妇科肿瘤学组研究 GOG-0213):一项多中心、开放标签、随机、3 期临床试验。
Lancet Oncol. 2017 Jun;18(6):779-791. doi: 10.1016/S1470-2045(17)30279-6. Epub 2017 Apr 21.
5
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.用于个性化癌症医学的患者来源恶性胸腔积液的培养与药物分析
PLoS One. 2016 Aug 22;11(8):e0160807. doi: 10.1371/journal.pone.0160807. eCollection 2016.
6
Laser Therapy Inhibits Tumor Growth in Mice by Promoting Immune Surveillance and Vessel Normalization.激光疗法通过促进免疫监视和血管正常化抑制小鼠肿瘤生长。
EBioMedicine. 2016 Sep;11:165-172. doi: 10.1016/j.ebiom.2016.07.028. Epub 2016 Jul 25.
7
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.源自恶性胸腔积液的人肺腺癌细胞培养物作为预测患者化疗敏感性的模型系统。
J Transl Med. 2016 Feb 29;14:61. doi: 10.1186/s12967-016-0816-x.
8
Intraperitoneal Perfusion Therapy of Endostar Combined with Platinum Chemotherapy for Malignant Serous Effusions: A Meta-analysis.恩度联合铂类化疗药物腹腔灌注治疗恶性浆液性胸腔积液的Meta分析
Asian Pac J Cancer Prev. 2015;16(18):8637-44. doi: 10.7314/apjcp.2015.16.18.8637.
9
Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.单药紫杉烷与含紫杉烷联合化疗作为晚期尿路上皮癌挽救治疗的对比
Eur Urol. 2016 Apr;69(4):634-641. doi: 10.1016/j.eururo.2015.07.042. Epub 2015 Aug 8.
10
Pembrolizumab versus Ipilimumab in Advanced Melanoma.帕博利珠单抗对比伊匹单抗用于晚期黑色素瘤。
N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19.